OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systemic benefit of radiation therapy via abscopal effect
Daniel J. Craig, Stephanie Ambrose, Laura Stanbery, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Daniel J. Craig, Stephanie Ambrose, Laura Stanbery, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Showing 8 citing articles:
Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects
Xuefeng Wang, Yu Wang, Yonggang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Xuefeng Wang, Yu Wang, Yonggang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma
Genwen Chen, Danxue Zheng, Yimin Zhou, et al.
Cancer Letters (2023) Vol. 582, pp. 216507-216507
Closed Access | Times Cited: 15
Genwen Chen, Danxue Zheng, Yimin Zhou, et al.
Cancer Letters (2023) Vol. 582, pp. 216507-216507
Closed Access | Times Cited: 15
Immunotherapy Plus Radiotherapy for the Treatment of Sarcomas: Is There a Potential for Synergism?
Jiaqiang Wang, Hong Ge, Zhichao Tian
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 385-397
Open Access | Times Cited: 4
Jiaqiang Wang, Hong Ge, Zhichao Tian
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 385-397
Open Access | Times Cited: 4
Progress in heavy ion cancer therapy at IMP and future development
Qiang Li, Xinguo Liu, Zhongying Dai, et al.
Malignancy Spectrum (2024) Vol. 1, Iss. 2, pp. 91-98
Closed Access | Times Cited: 1
Qiang Li, Xinguo Liu, Zhongying Dai, et al.
Malignancy Spectrum (2024) Vol. 1, Iss. 2, pp. 91-98
Closed Access | Times Cited: 1
Combination low-dose cyclophosphamide with check-point blockade and ionizing radiation promote an abscopal effect in mouse models of melanoma
Xing Luo, Ming Zeng
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 718-725
Open Access | Times Cited: 1
Xing Luo, Ming Zeng
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 718-725
Open Access | Times Cited: 1
Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group
Nam P. Nguyen, Juliette Thariat, Olena Gorobets, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4981-4981
Open Access | Times Cited: 2
Nam P. Nguyen, Juliette Thariat, Olena Gorobets, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4981-4981
Open Access | Times Cited: 2
Advancing cancer immunotherapy through emerging intratumoral delivery and biomedical imaging technologies
Eun-Seo Choi, Alexander F. Bagley, Sakib Haque, et al.
Materials Today Advances (2024) Vol. 24, pp. 100539-100539
Closed Access
Eun-Seo Choi, Alexander F. Bagley, Sakib Haque, et al.
Materials Today Advances (2024) Vol. 24, pp. 100539-100539
Closed Access
Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a patient with advanced metastatic renal cell carcinoma
Tingting Tan, Xiaotong Lin, Ling Jing, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Tingting Tan, Xiaotong Lin, Ling Jing, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
